Trial Profile
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Oct 2012
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Perphenazine
- Indications Cocaine-related disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 15 Oct 2012 Lead trial centre amended as reported by ClinicalTrials.gov.
- 15 Oct 2012 Planned End Date changed from 1 Oct 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 17 Jan 2009 New trial record.